Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
You'll get FREE Breaking News Alerts on new MS treatments as they are approved

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

This page is powered by Blogger. Isn't yours?



Scientists Accelerate Stem Cells’ Production of Brain Cells to Just Days, Study Reports

British scientists have accelerated from weeks to days the process by which stem cells generate brain cells, which could open the door to new treatment approaches for diseases such as MS.

Researchers at the Wellcome Trust Sanger Institute and colleagues at the University of Cambridge developed the new technique, called OPTi-OX, which speeds up stem cells’ production of muscle cells as well.

The study, “Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes,” was published in the journal Stem Cell Reports.

Human pluripotent stem cells are a special group of cells due to their ability to form any type of cell in the human body. This means they carry great promise not only for investigating the mechanisms of disease but also as potential therapies.

During human development, it takes nine to 12 months for a single brain cell to develop. Scientists have shortened the period to between three and 20 weeks, but that time frame still made the process of generating brain cells from pluripotent stem cells inefficient.

The British scientists used OPTi-OX to generate, in a matter of days, such differentiated cells as neurons, muscles and oligodendrocytes, or nervous system cells that create the myelin sheath protecting neurons. OPTi-OX stands for OPTimised inducible OvereXpression.

To make the three cell types from stem cells, they reprogrammed stem cells’ DNA to alter a limited number of genes. This led to the creation of a large and almost pure population of cells, all sharing an identity — that is, all being nerve or muscle cells.

OPTi-OX has the potential to generate other cell types in a short period, the researchers added.

“What is really exciting is we only needed to change a few ingredients — transcription factors — to produce the exact cells we wanted in less than a week,” Ludovic Vallier of the Wellcome Trust Sanger Institute, the author of the study, said in a press release, “We over-expressed factors that make stem cells directly convert into the desired cells, thereby bypassing development and shortening the process to just a few days.”

“When we receive a wealth of new information on the discovery of new cells from large scale projects, like the Human Cell Atlas, it means we’ll be able to apply this method to produce any cell type in the body, but in a dish,” said Daniel Ortmann, the study’s co-first author, from the University of Cambridge.

The Human Cell Atlas is a project whose goal is to create comprehensive reference maps of all human cells.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length
Click here to read more

Labels: ,

Go to Newer News Go to Older News